Teratogens

Name
Teratogens
Accession Number
DBCAT001141
Description

An agent that causes the production of physical defects in the developing embryo.

Drugs
DrugDrug Description
TazaroteneAn acetylenic retinoid used to treat fine wrinkles, mottled pigmentation of the skin, acne vulgaris, and plaque psoriasis.
IsotretinoinA retinoid used to treat severe recalcitrant acne.
ThalidomideA medication used to treat cancers, particularly newly diagnosed multiple myeloma, and erythema nodosum leprosum.
HadacidinNot Available
2-MethoxyethanolNot Available
Methyl pyrrolidoneN Methyl Pyrrolidone is under investigation for the treatment of Multiple Myeloma.
ZanubrutinibA kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.
VericiguatA soluble guanylate cyclase stimulator used to reduce heart failure-related hospitalization and cardiovascular death in patients with chronic systolic heart failure.
Azilsartan medoxomilAn angiotensin II receptor blocker used to treat hypertension alone or in combination with other antihypertensive agents, such as chlorthalidone.
BromoformNot Available
Arsenite ionNot Annotated
Drugs & Drug Targets
DrugTargetType
TazaroteneRetinoic acid receptor alphatarget
TazaroteneRetinoic acid receptor RXR-betatarget
TazaroteneRetinoic acid receptor gammatarget
TazaroteneRetinoic acid receptor betatarget
TazaroteneCytochrome P450 2C8enzyme
IsotretinoinRetinoic acid receptor alphatarget
IsotretinoinSerum albumincarrier
IsotretinoinRetinoic acid receptor gammatarget
IsotretinoinCytochrome P450 3A4enzyme
ThalidomideCytochrome P450 2C19enzyme
ThalidomideCytochrome P450 2C9enzyme
ThalidomideProstaglandin G/H synthase 1enzyme
ThalidomideProstaglandin G/H synthase 2enzyme
ThalidomideCytochrome P450 3A5enzyme
ThalidomideDNAtarget
ThalidomideProtein cereblontarget
Thalidomidealpha1-acid glycoproteintarget
ThalidomideCytochrome P450 3A4enzyme
ThalidomideCytochrome P450 1A1enzyme
ThalidomideCytochrome P450 2B6enzyme
HadacidinAdenylosuccinate synthetasetarget
HadacidinAdenylosuccinate synthetase isozyme 1target
HadacidinAdenylosuccinate synthetasetarget
ZanubrutinibCytochrome P450 3A4enzyme
ZanubrutinibP-glycoprotein 1transporter
ZanubrutinibCytochrome P450 2B6enzyme
ZanubrutinibTyrosine-protein kinase BTKtarget
ZanubrutinibEpidermal growth factor receptortarget
ZanubrutinibReceptor tyrosine-protein kinase erbB-2target
ZanubrutinibReceptor tyrosine-protein kinase erbB-4target
ZanubrutinibTyrosine-protein kinase ITK/TSKtarget
ZanubrutinibCytoplasmic tyrosine-protein kinase BMXtarget
ZanubrutinibTyrosine-protein kinase JAK2target
ZanubrutinibTyrosine-protein kinase Tectarget
ZanubrutinibTyrosine-protein kinase Blktarget
ZanubrutinibTyrosine-protein kinase JAK3target
ZanubrutinibProtein-tyrosine kinase 6target
ZanubrutinibTyrosine-protein kinase Fgrtarget
ZanubrutinibTyrosine-protein kinase FRKtarget
ZanubrutinibTyrosine-protein kinase Lcktarget
ZanubrutinibTyrosine-protein kinase TXKtarget
ZanubrutinibCytochrome P450 3A Subfamilyenzyme
VericiguatUDP-glucuronosyltransferase 1-9enzyme
VericiguatUDP-glucuronosyltransferase 1-1enzyme
VericiguatP-glycoprotein 1transporter
VericiguatATP-binding cassette sub-family G member 2transporter
VericiguatSerum albumincarrier
VericiguatGuanylate cyclase soluble subunit beta-1target
Azilsartan medoxomilType-1 angiotensin II receptortarget
Azilsartan medoxomilSerum albumincarrier
Azilsartan medoxomilCytochrome P450 2C9enzyme
Azilsartan medoxomilCytochrome P450 2C8enzyme
Azilsartan medoxomilCytochrome P450 2B6enzyme
Azilsartan medoxomilP-glycoprotein 1transporter